Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-99-012776
Filing Date
1999-03-31
Accepted
1999-03-31 00:00:00
Documents
9
Period of Report
1998-12-31

Document Format Files

Seq Description Document Type Size
1 10-K 10-K 206989
2 EXHIBIT 10.11 EX-10.11 17819
3 EXHIBIT 10.12 EX-10.12 71184
4 EXHIBIT 10.13 EX-10.13 23723
5 EXHIBIT 10.15 EX-10.15 126772
6 EXHIBIT 10.18 EX-10.18 4903
7 EXHIBIT 10.19 EX-10.19 4034
8 EXHIBIT 11.1 EX-11.1 1220
9 EXHIBIT 27 EX-27 2081
  Complete submission text file 0001047469-99-012776.txt   460926
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 100 CORPORATE NORTH STE 215 BANNOCKBURN IL 60015 7082958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12493 | Film No.: 99581323
SIC: 8731 Services-Commercial Physical & Biological Research